Read untitled text version

POSTER SESSION IV

PARKINSON'S DISEASE: DEEP BRAIN STIMULATION P04.001 Early Versus Delayed Bilateral Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Decision Analysis Alberto J. Espay, Jennifer E. Vaughan, Noël Burton, Connie Marras, Rob Fowler, Mark H. Eckman P04.002 Medium Frequency Subthalamic Stimulation for Axial Symptoms in Advanced Parkinson's Disease Mazen G. Jabre, George Nohra, Katia G. Habib, Boulos-Paul W. Bejjani P04.003 Pallidal Stimulation and Subthalamic Stimulation in Parkinson's Disease Patients May Lead to Equivalent Dose Reductions in Postoperative Doses of Medications Ashvini P. Premkumar, Mark Lyons, Renee Hillman, Mark Wheeler, Bryce Falk, Susan Lemens, Charles Adler, John Caviness, Erika Driver-Dunckley, Virgilio Gerald Evidente P04.004 Walking and Counting: Are PD Patients Doing the Same with Levodopa and Subthalamic Deep Brain Stimulation? Marianne Vaugoyeau, Stéphanie Cantiniaux, Marie Delfini, Tatiana Witjas, Jean Philippe Azulay P04.005 Assessing the Microlesion Effect of STN DBS Electrode Placement with FDG PET Michael H. Pourfar, Tanya P. Lin, Chris Tang, Vijay Dhawan, Andrew Feigin P04.006 Optokinematic Analysis of the Effect of Modified STN DBS Frequencies on Gait Disorders in Advanced Parkinson's Disease Caroline Moreau, Pierre Krystkowiak, Severine Bleuse, Jean Louis Blatt, Alain Duhamel, Alain Destee, Luc Defebvre P04.007 Repetitive Subthalamic Stimulation Disrupts Synaptic Transmission Recorded in Substantia Nigra Pars Reticulata Neurons Steven W. Johnson, Ke-Zhong Shen P04.008 Unilateral Thalamic or Subthalamic Nucleus DBS in Tremor Predominant PD: Differential Effects on Upper Limb Kinematics Mónica M. Kurtis, QiPing Yu, Annie Hsu, Linda Winfield, Blair Ford, Rachel SaundersPullman, Seth L. Pullman P04.009 Relief of Acquired Stuttering Associated with Parkinson Disease by Unilateral Left Subthalamic Brain Stimulation Harrison C. Walker, Deborah B. Boswell, Daniel B. Phillips, Barton L. Guthrie, Stephanie L. Guthrie, Anthony Nicholas, Erwin Montgomery, Ray Watts P04.010 Modeling Field Steering in the Brain with Segmented Electrodes: Next Generation Deep Brain Stimulation Therapy Gregory F. Molnar, Gabriela C. Miyazawa, Dick Stone

WEDNESDAY, APRIL 16 / 7:00 A.M.­10:00 A.M. FIRST AUTHORS STAND BY POSTER FROM 7:00 A.M.­8:30 A.M.

P04.011 Ketogenic Diet Prevents Cerebral Hypoxic Neurodegeneration in a Rat Model of Posthypoxic Myoclonus Kwok-Keung Tai, Daniel D. Truong P04.012 Cerebral Magnetic Resonance Imaging Findings in Wilson's Disease: Possible Relationship with Portal Hypertension Gaelle Bruneteau, Olivier Offret, Pascal Favrole, Vincent Navarro, France Woimant, Charles PierrotDeseilligny P04.013 Swiss Cheese Striatum: Clinical Spectrum Melinda S. Burnett, Keith Josephs, J. Ahlskog P04.014 Successful and Rapid Improvement of Tardive Dyskinesia with a Combination of Tetrabenazine, Clonazepam and Clozapine at Low Doses Jose M. Rabey, Tatiana Prokhorov, Eugenia Dobronevsky, Ala Miniovitch, Lea Pollak, Colin Klein P04.015 Improvement of Essential Tremor after Cerebellar Hemorrhage Alexander H. Rajput, Kinza Maxood, Ali H. Rajput P04.016 Anxiety in Parkinson's Disease: Clinical and Demographic Correlates Michael A. Klufas, Christine E. Boxhorn, Angela Y. Shih, Nadia M. Tsankova, Claire Henchcliffe, Melissa J. Nirenberg P04.017 Tremor in X-Linked Recessive Spinobulbar Muscular Atrophy (Kennedy's Disease) Helio Teive, Renato Munhoz, Lineu Werneck, Salmo Raskin P04.018 Arginine Does Not Distinguish Cerebellar Multiple System Atrophy from Other Ataxias Raquel C. Gardner, Jeremy D. Schmahmann P04.019 Evidence for Conversion of L-Dopa to Dopamine in Striatal Glial Cells Jose M. Rabey, Ola Saader-Mazbar, Olga Zalny,Yelena Loboda, John P. M. Finberg P04.020 Deep Brain Stimulation (DBS) in Patients with Parkinson's Disease (PD) Improves Motor Execution Rather Than Motor Planning Ralf Baales, Niels Allert, Hans Karbe PARKINSON'S DISEASE: SURGERY P04.021 Neuropsychological Functioning Following Subthalamic Gene Therapy for Parkinson's Disease Paul J. Mattis, Andrew Feigin, Chengke Tang, Matthew During, Michael Kaplitt, David Eidelberg P04.022 The Prevalence and Clinical Significance of Fatigue Following Deep Brain Surgery in Parkinson's Disease Benzi M. Kluger, Cynthia W. Garvan, Charles Jacobson, Dawn Bowers, Amanda Fogel, Barry Skoblar, Ramon Rodriquez, Hubert H. Fernandez, Michael S. Okun P04.023 Changes in Emotional Versus Physical Symptoms of Depression Following Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease Adriana M. Strutt, Michele York, Joseph Jankovic P04.024 Dopaminergic Dysregulation Syndrome in Parkinson's Disease: A Prospective Study in Patients Treated by Subthalamic Deep Brain Stimulation Jean-Philippe Azulay, Tatiana Witjas, Stéphanie Cantiniaux, Jean Regis, JeanClaude Peragut P04.025 Does Subthalamic Stimulation for Parkinson's Disease Improve Spouses? A One-Year Study of Mood, Burden and Quality of Life Thierry Soulas, Jean-Marc Gurruchaga, Stéphane Palfi, Serge Sultan, Gilles Fénelon P04.026 Patient Centered Outcomes for Deep Brain Stimulation Michael S. Okun, Amanda Fogel, Barry Skoblar, Hubert H. Fernandez, Ramon L. Rodriguez, Kelly D. Foote, Dawn Bowers P04.027 Dopasensitive Axial Involvement in Parkinson's Disease: A Long Term Evaluation under Subthalamic Deep Brain Stimulation Stéphanie Cantiniaux, Tatiana Witjas, Julien Mancini, Jean Regis, Jean-Claude Peragut, Jean-Philippe Azulay P04.028 The New Phenotype of Parkinson's Disease: The PostSubthalamic Stimulation Era BoulosPaul W. Bejjani, Mazen G. Jabre, George Nohra P04.029 Long-Term Gait Deterioration after Bilateral STN DBS Is Not Due to the Natural Progression of Parkinson's Disease Michele Tagliati, Isabelle Barnaure, Caitlin Martin, Ron L. Alterman P04.030 Intra-Operative X-Ray To Measure Distance between DBS Leads: A Reliability Study Leonard Verhagen Metman, Julie G. Pilitsis, Roy Bakay BEHAVIORAL NEUROLOGY: EMOTION AND MOOD P04.031 Neuroanatomical Correlates of Extraversion in Neurodegenerative Disease Marc Sollberger, Christine Stanley, Bruce Miller, Katherine Rankin P04.032 Parkinson's Disease, Subthalamic Nucleus and Emotional Processing Anne Buot, Marie-Laure Welter, Carine Karachi, Jean-Baptiste Pochon, Luc Mallet P04.033 The 2 and 5 nAchR Subunits Are Critical for Nicotine Withdrawal Renea M. Sturm, Ramiro Salas, Mariella De Biasi P04.034 Brain Regions for Smile and Panic Phenomena Induced during Intraoperative Test Stimulation in Obsessive Compulsive Disorder (OCD) Ihtsham U. Haq, Kelly D. Foote, Wayne K. Goodman, Hubert H. Fernandez, Atchar Sudhyadhom, Michael S. Okun, Charles Jacobson P04.035 Pregabalin Improves Pain in Fibromyalgia (FM) Patients Regardless of Baseline Anxiety and Depression Levels Lesley Arnold, L. Pauer, Ed Whalen, Jeannette Barrett, Teresa Leon P04.036 Cognitive, Functional and Behavioral Factors Associated with the Burden of Caring for Geriatric Patients with Cognitive Impairment or Depression: Evidence from a South American Sample Leonardo Bartoloni, Carol Dillon, Galeno Rojas, Cecilia M. Serrano, Leandro Loñ, Fernando E. Taragano, Gerardo Machnicki, Ricardo Allegri P04.037 Is Perception of Causes of Illness Related to Psychological Well-Being in ALS Patients? Alessandro Vignola, Alice Guzzo, Ilana Eldan, Luigi Sellitti, Antonio Ilardi, Paolo Ghiglione, Adriano Chiò P04.038 Pregabalin Pain Changes Associate with Anxiety and Depression Changes in Fibromyalgia Patients Lesley Arnold, L. Pauer, Ed Whalen, Jeannette Barrett, Teresa Leon BEHAVIORAL NEUROLOGY: LANGUAGE AND NUMBERS P04.039 Number Impairment in Corticobasal Degeneration Shira Koss, Luisa Vesely, Murray Grossman P04.040 Compromised Verb Associative Knowledge in Frontotemporal Dementia Luisa Vesely, Chivon Anderson, Peachie Moore, Murray Grossman P04.041 Selective NumberRelated Comprehension Deficits in Corticobasal Degeneration Vanessa Troiani, Jonathan Peelle, Luisa Vesely, Robin Clark, Murray Grossman P04.042 The Neural Basis of LeftLateralized and Bilateral Language Functions in Children and Young Adults Jennifer Vannest, Jerod Rasmussen, Jerzy Szaflarski, Katherine Szalewski, Vincent J. Schmithorst, Scott K. Holland P04.043 Verb and Noun Knowledge in Amyotrophic Lateral Sclerosis Alea N. Khan, Luisa Vesely, Peachie Moore, Laura Elman, Leo McCluskey, Murray Grossman

52

WEDNESDAY, APRIL 16 / 7:00 A.M.­10:00 A.M. MCCORMICK PLACE WEST CONVENTION CENTER / EXHIBITION HALL

P04.044 Language Specific, NonFluent Aphasia in a Bilingual Patient with Progressive Supranuclear Palsy Pinky Agarwal, Alida Griffith P04.045 Cortical Pathways of Nouns and Verbs' Processing Olivier Casez, Alexandre Krainik, Monica Baciu, Annik Charnallet, Olivier Moreaud P04.046 Wernicke's Aphasia Caused by Broca's Area Infarction: A PET Follow-Up Study Kun-Woo Park, Jee Hoon Roh, Sung-Bom Pyun, Sung-Eun Kim, Yu Mi Hwang, Ji Hyun Kim, Seong-Beom Koh AGING AND DEMENTIA: DIAGNOSIS OF DEMENTIA P04.047 Elevated CSF P-tau181 and Total-tau and Reduced P-tau181/T-tau Ratio in Pre-Symptomatic Familial Alzheimer's Disease John M. Ringman, Willam Seltzer, Greg Cole, Luis D. Medina, Yaneth Rodriguez, Arousiak Varpetian, Sophie Sokolow, Jaime Fitten, Freddy Ortiz, Jeffrey L. Cummings P04.048 Feasibility of BiomarkerBased Alzheimer's Disease Prevention Trials Joseph F. Quinn, Jeffrey Kaye, Thomas Montine, Briana Studer, John C. S. Breitner P04.049 Brain and Ventricular Volumetric Changes in Patients with Frontotemporal Lobar Degeneration: Results of a Longitudinal, Multicenter Study David Knopman, Clifford Jack, Neill Graff-Radford, Mario Mendez, Bruce Miller, Bradley Boeve, Richard Caselli, Nathaniel D. Mercaldo P04.050 Self-Administered Gerocognitive Examination (SAGE): Validity and Reliability of a Brief Cognitive Screening Instrument for Mild Cognitive Impairment (MCI) and Early Dementia Douglas Scharre, Chang Shu-Ing, David Beversdorf, Maria Kataki, Haikady Nagaraja, Robert Bornstein P04.051 Comparison of CoatedPlatelet Production between Patients with Alzheimer Disease and Frontotemporal Dementia Calin I. Prodan, Elliott Ross, Andrea Vincent, George L. Dale P04.052 Validation of a SelfAdministered Computerized Screening Test for Cognitive Impairment and Dementia Lauren V. Saunders, Benzi Kluger, Serdar Kirili, David Efros, Gregory Crucian, Cyndi Garvan, Annie Chau, Glen Finney, Kenneth Heilman P04.053 Protein Expression and Phosphorylation Profiles from Blood Lymphocytes Can Distinguish Patients with Alzheimer Disease from AgeMatched Controls Gerald Pfeffer, Joyce Lin H.Yeo, Claudia Jacova, Hong Zhang, Steven Pelech, Howard Feldman P04.054 Plasma A40 Is Associated with Very Early Cognitive Deficits in a Population-Based Sample of Older People James A. Mortimer, Amy Borenstein, Steven Younkin, Linda H. Younkin, David Loewenstein P04.055 Informant-Based Detection of Cognitive Decline in a PopulationBased Sample of African American Participants Monique M. Williams, Theodore K. Malmstrom, Douglas K. Miller, Mary A. Coats, Pamela Jackson, J. Philip Miller, John Morris AGING AND DEMENTIA: RISK FACTORS P04.056 Hippocampal Atrophy, Cortical Infarctions and Decreased NAA/Cr Have Additive Effects on the Risk of Progression to Dementia in MCI Kejal Kantarci, Stephen Weigand, Maria Shiung, Jennifer Whitwell, Selamawit Negash, David Knopman, Bradley Boeve, Peter O'Brien, Ronald C. Petersen, Clifford Jack P04.057 Relation of Hypertension to Mild Cognitive Impairment Christiane Reitz, Ming Xin Tang, Jennifer Manly, Richard Mayeux, Jose Luchsinger P04.058 Impact of White Matter Hyperintensity Volume Progression on Rate of Cognitive and Motor Decline Lisa Silbert, Stella Nelson, Diane Howieson, Milar Moore, Jeffrey Kaye P04.059 Hypoglycemic Episodes Increase the Risk of Dementia in Elderly Patients with Diabetes Mellitus Rachel Whitmer, Kristine Yaffe, Andrew Karter, Charles Quesenberry, Joseph Selby P04.060 Diabetes and Cognitive Systems in Older Black and White Persons Zoe Arvanitakis, David Bennett, Lisa Barnes P04.061 Apolipoprotein E (APOE) e4 Selectively Accelerates Age-Related Memory Decline Richard Caselli, Joseph G. Hentz, David Osborne, Marwan Sabbagh, Donald Connor, Geoffrey Ahern, Leslie Baxter, Steven Rapcsak, Michael Hutton, Eric Reiman P04.062 Duration of Diabetes Mellitus, Insulin Therapy, and Diabetic Complications Are Associated with Mild Cognitive Impairment: The Mayo Clinic Study of Aging Rosebud Roberts, Yonas O. Geda, David Knopman, Teresa Christianson, Vernon Pankratz, Bradley Boeve, Adrian Vella, Walter Rocca, Ronald Petersen P04.063 Vascular Conditions as Risk Factors for Dementia amongst Five Medicare Elderly Cohorts Baqar A. Husaini, Robert Levine, Majaz Moonis P04.064 Vascular Risk Factors Predict Executive Cognitive Impairment in Aging, MCI, and Dementia Bruce Reed, Dan Mungas, Sarah Farias, Evan Fletcher, Oliver Martinez, Charles DeCarli P04.065 Moderate Physical Exercise Is Associated with a Reduced Risk of Mild Cognitive Imapirment: A Population-Based Study Yonas E. Geda, Rosebud O. Roberts, David Knopman, Teresa J. Christianson, Vernon Pankratz, Ronald Petersen, Bradley Boeve, Eric Tangalos, Robert Ivnik, Walter Rocca P04.066 Predictors of Progression from Mild Cognitive Impairment (MCI) to Dementia in a Combined Clinical and Community Population Charles DeCarli, Bruce Reed, Sarah Farias, Evan Fletcher, Oliver Martinez, Mario Ortega, Dan Mungas P04.067 Midlife Serum Total Cholesterol and Risk of Alzheimer's Disease and Vascular Dementia Three Decades Later Alina Solomon, Miia Kivipelto, Jufen Zhou, Rachel A. Whitmer P04.068 Height and Incidence of Dementia. The 3C Study Carole Dufouil, Stanley Lemeshow, J. Dartigues, Karen Ritchie, Michel Poncet, Christophe Tzourio, Annick Alperovitch P04.069 Coagulation Derangements Associated to Markers of Inflammation in Vascular Dementia Mariasanta Napolitano, Domenico De Lucia, Diletta D'Eufemia, Giovanni Ragozzino P04.070 Relation of Serum Markers of Oxidative Stress to Mild Cognitive Impairment and Cognitive Decline Zoe Arvanitakis, Robert S. Wilson, Jeremiah F. Kelly, David Bennett P04.071 Impact of Alcohol Use, Smoking and Apolipoprotein-E Epsilon 4 Allele (APOE 4) on Age of Onset of Late Onset Alzheimer's Disease (LOAD) Dylan Harwood, Warren Barker, Peter St. George-Hyslop, David Loewenstein, Ranjan Duara P04.072 Cardiorespiratory Fitness and Brain Atrophy in Early Alzheimer's Disease Jeffrey M. Burns, Benjamin B. Cronk, Joseph Donnelly, George P. Thomas, Amith Harsha, William S. Brooks, Russell H. Swerdlow P04.073 Smoking Is Associated with Increased Brain Atrophy Rates on Serial MRI Scans in Men but Not Women with Alzheimer's Disease Brittany N. Dugger, Denise Reyes, Scott A. Przybelski, Stephen Weigand, David Knopman, Bradley Boeve, Ronald Petersen, Jeffery Gunter, Clifford Jack P04.074 Associations between White Matter Lesions, Plasma Total Homocysteine and Methylenetetrahydrofolate Reductase Polymorphism in Alzheimer's Disease Sung Rae Kim, Seong Hye Choi, So-Hyun Kim, Jeong Lee, Ki-Hwan Ji, Eun-Cheol Song, Joung-Ho Rha, Choong-Kun Ha P04.075 Diabetes Mellitus: Risk or Protective Factor in ALS? Alicia R. Salamone, Paul Schulz, Adriana Macias, Emily J. McDowell, Michael Wheaton RISK FACTORS FOR NEUROLOGIC DISEASES P04.076 Prospective Studies on Smoking and Risk of Amyotrophic Lateral Sclerosis Hao Wang, Marc G. Weisskopf, Eilis J. O'Reilly, Giancarlo Logroscino, Marjorie L. McCullough, Arthur Schatzkin, Larry N. Kolonel, Alberto Ascherio P04.077 The Piemonte and Valle d'Aosta ALS Register (PARALS): A 10Year Epidemiological Prospective Study Adriano Chiò, Andrea Calvo, Maurizio Leone, Edo Bottacchi, Paolo Ghiglione, Enrico Cavallo, Stefania Cammarosano, Roberto Mutani P04.078 Evidence for a Synergistic Association between Hippocampal Atrophy and Severe White Matter Lesions on the Risk of Dementia. The 3C-Dijon Study Ophelia Godin, Carole Dufouil, Olivier Rouhaud, Pauline Maillard, J. Dartigues, Fabrice Crivello, Hervé Lemaître, Annick Alperovitch, Bernard Mazoyer, Christophe Tzourio P04.079 Association of the Periodontitis Pathogen Porphyromonas gingivalis with Poor Memory: Analysis of the Third National Health and Nutrition Examination Survey (NHANES-III) James Noble, Luisa N. Borrell, Panos N. Papapanou, Mitchell Elkind, Nikolaos Scarmeas, Clinton Wright P04.080 Risk of Incident Parkinson's Disease and Parkinsonism in Essential Tremor: A Population-Based Study Julián Benito-León, Elan D. Louis, Félix Bermejo-Pareja P04.081 Prenatal and Early Life Factors and Risk of Parkinson's Disease Hannah E. Gardener, Honglei Chen, Gao Xiang, Michael Schwarzschild, Donna Spiegelman, Alberto Ascherio P04.082 Different Prevalence Rates of Parkinson's Disease in Urban and Rural Areas: Population-Based Study in Taiwan Horng-Huei Liou, Chih-Chuan Chen, Ta-Fu Chen,Yuarn-Chung Hwang, Tony Hsiu-Hsi Chen

POSTER SESSION IV

53

POSTER SESSION IV

P04.083 Factors Associated with a Steep Rise in the Incidence of MS on Crete over the past 25 Years Theodora Panou, Maria Mylonaki, Dimitra Kotzamani, Gregory Chlouverakis, Vasileios Mastorodemos, Andreas Plaitakis P04.084 Cats as Domestic Pets Reduce the Risk of Cardiovascular Diseases. Results from the Second National Health and Nutrition Examination Study Mortality FollowUp Study Muhammad Zeeshan Memon, Adnan I. Qureshi, M. Fareed K. Suri, Mustapha Ezzeddine ANTERIOR HORN: CLINICAL TRIALS AND RISK FACTORS P04.085 A Randomized, PlaceboControlled, Sequential Trial of Valproic Acid in ALS Sanne Piepers, Sonja De Jong, Jan H. Veldink, Ingeborg Van der Tweel, W.-Ludo Van der Pol, Geert-Jan G. Groeneveld, Esther V. Uijtendaal, Imke Bartelink, H.-Bart Van der Worp, H-Jurgen Schelhaas, Marianne De Visser, J. B. M.-Vianney De Jong, John H. J. Wokke, Leonard Van den Berg P04.086 A Phase I-II Multicenter Study on G-CSF in Amyotrophic Lateral Sclerosis (STEMALS) Adriano Chiò, Gabriele Mora, Claudia Caponnetto, Gabriele Siciliano, Mario Sabatelli, Vincenzo La Bella, Vincenzo Silani, Cristina Moglia, Gianluigi Mancardi, Piero Tonali, Andrea Calvo, Roberto Mutani, Massimo Corbo, Rosanna Scimè, Giuseppe D'Onofrio, Mario Petrini, Mario Melazzini, Francesca Gualandi, Corrado Tarella P04.087 Transplantation of Neural Precursor Cells into the Central Nervous System of ALS Patients: the First Neuropathological Study Maria Teresa Giordana, Silvia Grifoni, Barbara Votta, Roberto Navone, Consuelo Valentini, Andrea Calvo, Adriano Chiò P04.088 Pyrimethamine Reduces SOD1 Levels in Familial ALS: Assessment of Efficacy, Safety and Tolerability Dale Lange, Alexander Shtilbans, Gregory Seidel, Sean Scott, Daniel Benjamin P04.089 Progesterone as a New Treatment Option for Amyotrophic Lateral Sclerosis Patients: Open Trial and Survival Analysis Gisella M. Gargiulo Monachelli, Gabriel E. Rodriguez, Maria Claudia Gonzalez Deniselle, Alejandro F. De Nicola, Roberto E. P. Sica P04.090 Angiogenin Haplotypes in a Swedish Sporadic ALS Dataset David S. Lynch, Matthew J. Greenway, Simon Cronin, Peter Andersen, Orla Hardiman P04.091 Evidence of Reduced Frequency of ALS in an Ethnically Mixed Population: A Population-Base Mortality Study Orla Hardiman, Joel Gutierrez, Gloria Lara, Tatiana Zaldivar

WEDNESDAY, APRIL 16 / 7:00 A.M.­10:00 A.M. FIRST AUTHORS STAND BY POSTER FROM 7:00 A.M.­8:30 A.M.

P04.092 Paraplegin Mutations in Apparently Sporadic Adult-Onset Upper Motor Neuron Syndromes Frans Brugman, Hans Scheffer, Willy Nillesen, John Wokke, Marianne De Visser, Eleonore Aronica, Leonard Van den Berg P04.093 Evidence for a Chronic and Long Lasting Hyperactivity in ALS Patients William Camu, Agnes Gonzalez, Nicolas Pageot, Raoul Juntas Morales P04.094 Systemic Low-Grade Inflammation in Patients with Amyotrophic Lateral Sclerosis Daniel Keizman, Ori Rogowski, Shlomo Berliner, Maya Ish-Shalom, Natalie Maimon, Ditza Gross, Beatrice Nefussy, Irena Artamonov, Ygal Tsehori, Vivian E. Drory P04.095 Profile of Amyotrophic Lateral Sclerosis with and without Vascular Risk Factors: Results of a Clinical Database Study Evelyne Matteau, Martine Simard, Pierre Provencher, Jean-Pierre Bouchard, Francois Salachas, Lucette Lacomblez, Monique D'Amour, Vincent Meininger, Guy Rouleau, Nicolas Dupre ANTERIOR HORN: BIOMARKERS P04.096 Diffusion Tensor MRI of the Cervical Cord as a Tool To Monitor Disease Progression in ALS Federica Agosta, Paola Valsasina, Stefania Sala, Domenico Caputo, Michele Perini, Alessandro Prelle, Elisa Fruguglietti, Fabrizio Salvi, Ilaria Bartolomei, Massimo Filippi P04.097 Whole-Brain Metabolite Alterations and Their Correlations with Upper Motor Neuron (UMN) Function Measures in Amyotrophic Lateral Sclerosis (ALS) Khema R. Sharma, Varanavasi Govindaraju, Brian Bowen, Claudia Domenig, Andrew Maudsley P04.098 Interleukin 4 in ALS Preetha Muthusamy, Terry H. Patterson, Jeffrey S. Deitch, Anahita F. Deboo, Marielle J. Perrault, Guillermo M. Alexander P04.099 Elevated Plasma Homocysteine Levels in Patients with Amyotrophic Lateral Sclerosis Stefano Zoccolella, Isabella L. Simone, Paolo Lamberti, Luigi M. Specchio, Vito Samarelli, Rosanna Tortelli, Eustachio D'Errico, Roberta Pelliciari, Raffaella Messina, Paolo Livrea, Giancarlo Logroscino P04.100 Study of Corticospinal Tract in Amyotrophic Lateral Sclerosis Using Diffusion Tensor Imaging Celia OrejaGuevara, Francisco J. Rodriguez de Rivera, Rafael Alonso-Clarke, Juan Alvarez-Linera, Exuperio Diez-Tejedor P04.101 Combined Motor Cortex Proton Magnetic Resonance Spectroscopy (1H-MRS) and Corticospinal Tract (CST) Magnetization Transfer Ratio (MTR) Predict Disease Progression and Survival in Amyotrophic Lateral Sclerosis (ALS): A Target for Clinical Trials in ALS Omar Khan, Megan Mackenzie, Fen Bao, Ramya Penmesta, Ronald Bailey, Michael McCaffrey, Zahid Latif,Yuan Yang, Stephanie Hreha, Christina Caon, Agnes Ascadi, Richard Lewis EMERGING STROKE BIOMARKERS P04.102 Inflammatory Cytokines as Predictors of Clinical Outcome after Acute Ischemic Stroke Kachi Illoh, Daniel Arreola, Kamayani Khare, Orieji Illoh, James Grotta, Charles Streckfus P04.103 Metabolic Syndrome and Ischemic Stroke/TIA: Is There a Relationship? Tim Mikesell, Donna Gilski, Dipal Chokshi, Neil Shah P04.104 Lower Serum Triglycerides: Potential Markers for Poor Outcomes in Acute Ischemic Stroke Lekshmi Vaidyanathan, Gautam Kumar, Anjali Bhagra, Wyatt W. Decker, Latha Stead P04.105 Hyperglycemia as a Prognostic Factor in Ischemic Stroke. Results of a Multicentric Study Carolina León-Jiménez, Carlos Cantú-Brito, Antonio Arauz, Fernando Barinagarrementeria, Jose Ruiz-Sandoval, Fabiola Gonzalez-Romero, Erwin Chiquete P04.106 Impairment in Glomerular Barrier or Filtration Rate Is Associated with Stroke Occurrence Bruce Ovbiagele P04.107 Depression in High-Density Lipoprotein Levels at Ischemic Stroke Presentation Andrew N. Russman, Lonni R. Schultz, Iram Zaman, Mohammed Rehman, Brian Silver, David R. Nerenz P04.108 Relationship of Post Acute Ischemic Stroke Ionised Magnesium and Calcium to Serum Troponin and Mortality Aarti Sarwal, Ousama Dabbagh, Audrey Pichair, Megan Kowal, Tiffany Bohon, Scott Norris, Mandeep Garewal, Pradeep Sahota P04.109 Tau Protein as a Serum Marker of Ischemic Stroke Joanna E. Bielewicz, Jacek Kurzepa, Halina BartosikPsujek, Elzbieta Czekajska-Chehab, Urszula Chyrchel, Joanna Wojczal, Anna Szczepanska-Szerej, Zbigniew Stelmasiak P04.110 Granulocyte ColonyStimulating-Factor Is an Independent Prognostic Factor of Poor Outcome in Patients with Acute Ischemic Stroke Shih-Chieh Yu, Chin-San Liu PREDICTORS OF STROKE RISK AND OUTCOME P04.111 Cell Death Pathways; Activated Caspase-3 and PARP in Ischemic Human Stroke Tiina R. Sairanen, Rita Szepesi, Marja-Liisa Karjalainen-Lindsberg, Anders Paetau, Perttu Lindsberg P04.112 Cryptogenic Stroke May Be Associated with Lower High-Density Lipoprotein Levels Iram F. Zaman, Mohammed F. Rehman, Lonni R. Schultz, David R. Nerenz, Andrew N. Russman P04.113 Plasma Homocysteine as a Risk Factor for Strokes in Ghanaian Adults Albert K. Akpalu P04.114 Absence of Association between a Risk Gene for Myocardial Infarction and Common Stroke Robin Lemmens, An Goris, Wim Robberecht, Vincent Thijs P04.115 The ER-alpha PvuII Polymorphism Contributes to the Pathogenesis of Intracranial Aneurysm Sherine Abboud, Boris Lubicz, Jose G. Riberio Vaz, Christian Raftopulos, Massimo Pandolfo P04.116 Variability of Blood Pressure Management in Intracerebral Hemorrhage Does Not Affect Outcome Dulka Manawadu, Amrita Roy, Kim Orwaard, Negar Asdaghi, Ken Butcher P04.117 Seizures Following Intracerebral Hemorrhage: Risks and Implications for Therapy Martina Vendrame, Zulfi Haneef, S. Azizi P04.118 Prediction of Mortality after Aneurysmal Subarachnoid Hemorrhage: The Importance of the Admittance Blood Glucose Jose Luis Ruiz Sandoval, Erwin Chiquete, Miguel Angel Andrade Ramos, Lucia Elizabeth Alvarez Palazuelos, Carmen Ruiz Sandoval P04.119 Initial Perihematomal Edema Volume Is an Independent Predictor of Outcome at 3 Months FollowUp in Patients with Spontaneous Intracerebral Hemorrhage (SICH) Ahmed El-Gengaihy, Hafiz Khan, Ameer Hassan, Rasha Fahmy, Ammar AlKawi, Jawad F. Kirmani P04.120 Risk Factors of Progressive Motor Deficits in Patients with Acute Pontine Infarction Semi Oh, Suk Jae Kim, Byung-Su Kim, Chin-Sang Chung, Kwang Ho Lee, Gyeong-Moon Kim

54

WEDNESDAY, APRIL 16 / 7:00 A.M.­10:00 A.M. MCCORMICK PLACE WEST CONVENTION CENTER / EXHIBITION HALL

STROKE RISK FACTORS AND OUTCOMES P04.121 Cerebral Venous Sinus Thrombosis Etiologies in Adults: A Comprehensive Review Farzad Fatehi, Mohammad Saadatnia, Keivan Basiri, Gilda Kianimehr P04.122 Transfusion of Blood Products Is an Independent Predictor of Mortality in Acute Ischemic Stroke Patients Orieji Illoh, Joe Lucke, Sung Sug Yoon, Kachi Illoh P04.123 Validation of the ABCD Score To Predict Stroke Risk after TIA: A Population-Based Study Amy L. Fothergill, Teresa J. Christianson, Robert Brown, Alejandro D. Rabinstein P04.124 Impact of Modifiable Etiologic Factors on the Burden of Stroke: The Rotterdam Study Michiel J. Bos, Peter Koudstaal, Albert J. Hofman, Monique Breteler P04.125 Hyperglycemia Does Not Predict Functional Outcome in Lacunar Strokes M. Fernanda Bellolio, Rachel Gilmore, Lekshmi Vaidyanathan, Sailaja Enduri, Smitha Suravaram, Wyatt W. Decker, Alejandro Rabinstein, Robert Brown, Latha Stead P04.126 Infections and Risk of Ischemic Stroke: Causal or Casual Relationship? Maria C. Zurru, Claudia Alonzo, Laura Brescacin, Juan I. Rojas, Marina Romano, Belen Piaggio, Maia Gomez Schneider, Luis Camera, Gabriel Waisman, Edgardo Cristiano STROKE MANAGEMENT AND OUTCOME P04.127 A Comparison of Holter Monitoring and Continuous Cardiac Telemetry in the Detection of Arrhythmias Following Ischemic Stroke or Transient Ischemic Attack Marc A. Lazzaro, Maliha Aslam, Vivien Lee, Kousik Krishnan, Shyam Prabhakaran P04.128 Presence of an Ipsilateral Fetal Posterior Cerebral Artery in Stroke Patients Correlates with Better Clinical Outcomes Ammar AlKawi, Muhammad S. Faisal, Adnan I. Qureshi, Hafiz M. Khan, Jawad F. Kirmani P04.129 Sex Disparities in Ischemic Stroke Care and Outcome in an Emerging Country. The Argentinian National Stroke Registry (ReNACer) Luciano A. Sposato, Rafael Zamora, Cristina Zurru, Maria Martha Esnaola, Osvaldo Fustinoni, Gustavo Saposnik P04.130 Combined Assessment of NSE, S 100, and Somatosensory Evoked Potentials for the Prediction of Short Term Outcome in Acute Ischemic Stroke Walter F. Haupt, Ghesal M. Chopan, Wei-Chi Liu, Jan Sobesky P04.131 Trend of Stroke Hospitalization and Changes in Hospital Outcomes in Aragon (Spain), 1999-2006 José R. Ara, José L. Capablo, Jesús Martín, Raquel Alarcia, Daniel Sagarra, Javier Marta P04.132 Effect of Ventriculostomy on Outcome in Intracranial Hemorrhage with Intraventricular Extension Sushant Kale, Nandakumar BangaloreVittal, Wei Tang, Salah Keyrouz, James Schmidley P04.133 Thrombolytic Therapy for Acute Stroke in Pakistan Hazim Barohi, Mohammad Wasay, Safia Awan, Abdul Malik, Nadir A. Syed STROKE CARE QUALITY AND OUTCOMES P04.134 Escalating Levels of Access to In-Hospital Care and Stroke Mortality Gustavo Saposnik, Jimming Fang, Martin O'Donnell, Vladimir Hachinski, Moira Kapral, Michael Hill P04.135 Participation in PeerLed Support Groups Improves Use of Secondary Stroke Prevention Measures Christine Cowles, Stanley Tuhrim, John Brust, Barbara Koppel, Jesse Weinberger, Carol Horowitz, Mark Chassin P04.136 Incidence of Stroke in Alaska Native People Brian Trimble, Rebecca Hamel, Lisa Bulkow, Anne Lanier, Ellen Provost, Ronnie Horner P04.137 Stroke Outcome in Those over 80: A Canadian Study of the Approaching "Silver Tsunami" Gustavo Saposnik, Robert Cote, Jeffrey Minuk, Gordon Gubitz, Stephen Phillips, Neville Bayer, Sandra Black, Stroke Outcome Research (SORCan) Working Group P04.138 Risk Factors for Hospital Acquired Pneumonia among Stroke Patients Danish E. Bhatti, Reza Pakdaman, Ankur Patel, M. Fareed Suri, Adnan Qureshi, Afshin Divani P04.139 JCAHO Primary Stroke Center Core Measures: Influence of Stroke Care Unit Anand G. Vaishnav, Creed Pettigrew, Michael Dobbs, Stephan Ryan, Malhar Jhaveri, Manan Jhaveri, Lisa Bellamy P04.140 Stroke Outcomes Better for Patients Treated by Neurologists Judith H. Lichtman, Norrina B. Allen, Emi Watanabe,Yun Wang, Lisa C. Barry, Larry Goldstein P04.141 The Impact of ACGME Duty Hours Regulations and the July Phenomenon on Stroke Outcomes Tobias Walbert, David Preston, Michael Degeorgia, Amer Alshekhlee P04.142 Importance of Subjective Symptoms for Health-Related Quality of Life in Post-Stroke Patients ­ Assessment Using SF-36 (OASIS Study) Yukito Shinohara P04.143 On the Use of Simon's Two-Stage Optimal Design for Phase II Trials in Stroke Recovery Rebecca B. McNeil, Beth Rush, Thomas Brott, James Meschia NEURAL REPAIR/ REHABILITATION:CLINICAL/ STROKE P04.144 Clinically Meaningful Differences of the Ashworth Scale in Patients Suffering from Chronic Post-Stroke Upper Limb Spasticity David Charles, Manasee Shah, Amanda M. VanDenburgh, Susan Abu-Shakra, Jon Wagg, Tatiana Khariton, Steven Hua, Frederick Beddingfield, Mitchell Brin P04.145 Subjective Postural Vertical in Patients with Lateropulsion Following Stroke: A Pilot Comparison Study Suzanne R. Babyar, Michael Reding P04.146 Consistent Efficacy of Botulinum Toxin Type A in a MetaAnalysis from Seven Multicenter Studies of Upper Limb Spasticity in Chronic Post-Stroke Patients Glenn D. Graham, Mitchell F. Brin, Amanda M. VanDenburgh, Susan Abu-Shakra, Steven Hua, Jonathan Wagg, Tatiana Khariton, Frederick C. Beddingfield III P04.147 Retinal Microperimetry as a Means To Assess Visual Field Expansion in Visual Restoration Therapy Mohamad Chmayssani, Brandon Minzer, Nina Saxena, Roy Arogyasami, Ronald Lazar, Vivienne C. Greenstein, Randolph Marshall P04.148 Differential Effects of High-Frequency rTMS on Movement Kinematics and Neural Activation in Subcortical and Cortical MCA Stroke Mitra Ameli, Christian Grefkes, Ling Wang, Manuel Dafotakis, Marc Tittgemeyer, Hans Karbe, Gereon Fink, Dennis Nowak P04.149 A Pilot Study of ActivityBased Therapy in Upper Extremity Motor Recovery Post Stroke. A Randomized Control Trial Meheroz H. Rabadi, Roseann Cardi, Michael Galgano, Daniel Lynch, Bruce Volpe P04.150 Rehabilitation Hospital Versus Nursing Home Setting for Rehabilitation Following Stroke: A Case Matched Controlled Study, Phase 2 Ricardo Cruz, Sarada Sakamuri, Michael Reding P04.151 Proportional Motor Improvement: A New Rule in Stroke Recovery? Daniel Antoniello, Brandon M. Minzer, Eric Zarahn, Ronald M. Lazar, Randolph Marshall, John Krakauer P04.152 Effect of Antidepressant Choice on FIM Efficiency during Inpatient Rehabilitation Following Stroke Ricardo Cruz, Rolf Martin, Rajiv Ratan, Michael Reding MULTIPLE SCLEROSIS AND RELATED DISEASES: OUTCOMES AND SCALES I P04.153 Brain MR Changes and Cognitive Impairment May Predict Short-Term Disease Progression in Benign Multiple Sclerosis Emilio Portaccio, Maria Pia Amato, Benedetta Goretti, Marco Battaglini, Maria Laura Stromillo, Valentina Zipoli, Maria Letizia Bartolozzi, Leonello Guidi, Gianfranco Siracusa, Antonio Giorgio, Sandro Sorbi, Antonio Federico, Nicola De Stefano P04.154 Memory, Working Memory, and Processing Speed Significantly Improve after Participation in a SixWeek Comprehensive Rehabilitation Cognitive Program Joshua Bacon, J. Fromm, Rebecca Neuhaus, Jennifer Shuldiner, Joseph Herbert P04.155 EDSS and MRI Burden of Disease Predict Cognitive Status at 16 Years: Data from the IFNB-1b Long Term Follow-Up Study Dawn Langdon, Anthony Reder, Douglas Goodin, Anthony Traboulsee, David Li, Karola Beckmann, Andreas Konieczny, George Ebers P04.156 Progression of Disability over 2 Years Predicts Disability at 8 Years in Relapsing MS: Analysis from the Phase 3 Clinical Trial of Intramuscular Interferon Beta-1a Richard Rudick, Jar-Chi Lee, Robert Bermel, Bianca Weinstock-Guttman, Dennis Bourdette, Carlo Tornatore, Hao Zhang, Phil You, Robert Hyde P04.157 The Burden of Mental Comorbidity in Multiple Sclerosis: Frequent, Underdiagnosed, and Under-Treated Ruth Ann Marrie, Ralph Horwitz, Gary Cutter, Tuula Tyry, Denise Campagnolo, Timothy Vollmer P04.158 Adding Vision Increases the Capacity of the Multiple Sclerosis Functional Composite (MSFC) To Identify Reductions in Neurological Impairment and Quality of Life Sally C. Chang, Dina Jacobs, Clyde Markowitz, Steven Galetta, Laura Balcer P04.159 Predictors of Disability in Secondary Progressive MS: A Multimodal MRI Study Tom D. Hayton, Julian Furby, Kenneth J. Smith, Daniel Altmann, Robert Brenner, Jeremy Chataway, Nic Fox, Richard Hughes, Kelvin Hunter, Daniel Tozer, David Miller, Raju Kapoor

POSTER SESSION IV

55

POSTER SESSION IV

P04.160 Screening for Cognitive Impairment in Multiple Sclerosis (MS): Evaluation of the HIV Dementia Scale (HDS) Brandon Barton, Wenqing Fan, Sue Leurgans, Clifford Smith, Russell Bartt P04.161 Decreased Volume of Subcortical Activation during Complex Finger Tapping Correlates with Increasing Level of Fatigue in Patients with MS Robert A. Bermel, Lael Stone, Ruth-Ann Marrie, Katherine Koenig, Erik Beall, Craig I. Horenstein, Mark J. Lowe, Micheal D. Phillips P04.162 Low-Contrast Letter Acuity Scores Reflect Vision-Specific and Overall Health-Related Quality of Life in Multiple Sclerosis Ellen M. Mowry, Dina Jacobs, Clyde Markowitz, Steven Galetta, Laura Balcer P04.163 Remote Automated Neuropsychological Assessment Metrics (ANAMTM) Measures Predict Performance on Neuropsychological Measures Used in Multiple Sclerosis Shira Kurtz, Robert Kane, Mitchell Wallin, Heidi Maloni, Alison Cernich, Terry Lee-Wilk, Walter Royal, Catherine Rogers, Jeffrey Wilken, Cynthia Sullivan, Christopher Bever P04.164 Identification of Cognitive Impairment in MS Patients Using the Automated Neuropsychological Assessment Metrics (ANAMTM) Computerized Test System Administered over the Internet Robert L. Kane, Mitchell Wallin, Heidi Maloni, Alison Cernich, Terry Lee-Wilk, Shira M. Kurtz, Walter Royal, Catherine Rogers, Jeffrey Wilken, Cynthia Sullivan, Christopher Bever P04.165 The Computerized Automated Neuropsychology Assessment Metrics as Triage Measure for Assessing the Cognitive Impairment of Patients with Multiple Sclerosis Francesca Bagnato, Susan K. Stern, Joan Ohayon, Mary Ehrmantraut, Fredric Cantor, Antonio Gallo, Iordanis E. Evangelou, Vasiliki N. Ikonomidou, Shira Kurtz, Terry Lee-Wilk, Henry McFarland, Robert Kane P04.166 Pre-Existing Comorbidity in MS Is Associated with Greater Diagnostic Delays and Greater Disability at Diagnosis Ruth-Ann Marrie, Ralph Horwitz, Gary Cutter, Tuula Tyry, Denise Campagnolo, Timothy Vollmer P04.167 Clinical and Neuropsychological Predictors of Neuropsychiatric Symptoms in Subjects with MS and Cognitive Impairment Jesus Lovera, Elliot Frohman, Theodore Brown, Daniel Bandari, Katherine Wild, Laurie Rilling, Vijayshree Yadav, Ruth Whitham, Olaf Stuve, Dennis F. Bourdette

WEDNESDAY, APRIL 16 / 7:00 A.M.­10:00 A.M. FIRST AUTHORS STAND BY POSTER FROM 7:00 A.M.­8:30 A.M.

P04.168 Cognitive Performance in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis (CIS): Baseline Data from CogniCIS, a Multinational Longitudinal Study Dawn Langdon, Eva-Maria Wicklein, Peter Scherer, Sten Fredrickson P04.169 Natalizumab Reduces Multiple Sclerosis Severity: Analysis of Patients from the AFFIRM and SENTINEL Studies Using the Multiple Sclerosis Severity Scale Joseph Herbert, Ludwig Kappos, Peter Calabresi, Christian Confavreux, Steven Galetta, Gavin Giovannoni, Eva Havrdova, Michael Hutchinson, Fred Lublin, David Miller, Paul W. O'Connor, J. Phillips, Chris Polman, Ernst-Wilhelm Radue, Richard Rudick, William Stuart, Andrzej Wajgt, Bianca Weinstock-Guttman, Daniel Wynn, Joshua Bacon, Ilya Kister, Amy Pace, Michael Panzara P04.170 Relationship between Cognitive Impairment and Magnetic Resonance Imaging Disease Parameters in Patients with Early Relapsing-Remitting Multiple Sclerosis: Results from the Multicenter COGIMUS (COGnition Impairment in MUltiple Sclerosis) Study Francesco Patti, Maria Pia Amato, Maria Rosalia Tola, Maria Trojano, Paolo Ferrazza, Andrea Fausto Lijoi, Stefano Bastianello P04.171 Profiles of Performance of the PASAT with "Dyad Score" in Different Subtypes of Multiple Sclerosis Bruno Lenne, Charlotte Crinquette, Alexandre Mackowiak, Philippe Gallois, Patrick Hautecoeur P04.172 Variability in the EDSS: What Does It Mean for Progression? Stacey S. Cofield, Gary R. Cutter, Fred Lublin, Jerry Wolinsky, Robin Conwit P04.173 Quantitative Functional Tests and Patient Self-Report: Assessing the Relative Sensitivities of the Timed 25-Foot Walk and the 9Hole Peg Test to Worsening Reported by Patients with Multiple Sclerosis Allison S. Drake, J. Aubrey Duquin, Bianca Weinstock-Guttman, Barbara Teter, Ralph Benedict, Cornelia Mihai, Carl Granger, Fredrick Munschauer P04.174 Cognitive Performance in Early Multiple Sclerosis (MS): Baseline Data from CogniMS, a Multinational Longitudinal Study Sten Fredrickson, Eva-Maria Wicklein, Peter Scherer, Dawn Langdon P04.175 Correlations between Auditory Consonant Trigram Test, Paced Auditory Serial Addition Test Health-Related Quality of Life during and after Treatment of Relapses in Patients with Multiple Sclerosis Serkan Ozakbas, Turan Poyraz, Derya Kaya, Egemen Idiman P04.176 Effect of Relapse on Cognition for Patients with Multiple Sclerosis (MS) Charlotte Crinquette, Bruno Lenne, Alexandre Mackowiak, Patrick Hautecoeur P04.177 Toward a Specific Revalidation Regarding Cognitive Troubles in Multiple Sclerosis (MS): PROCOG-SEP Hélène Brissart, Marianne Leroy, Marc Debouverie P04.178 The Interferon Beta-1b 16-Year Long-Term Follow-Up Study: Neutralizing Antibodies and Clinical Outcomes Anthony T. Reder, George C. Ebers, Douglas S. Goodin, David Li, Anthony Traboulsee, Karola Beckman, Andreas Konieczny P04.179 Predictors of Poor Sleep Quality in Multiple Sclerosis Daria Trojan, Christel Renoux, Amit Bar-Or, Douglas Arnold, Stan Shapiro, Ann Robinson, Jean-Pierre Le Cruguel,Yves Lapierre, John Kimoff, Deborah Da Costa P04.180 Patients with Multiple Sclerosis Have Higher Rates of Sleep Disturbances: A Case-Control Study Joseph Finkelstein, Eunme Cha P04.181 Pain in Patients with Multiple Sclerosis: Effects of Natalizumab Deborah Miller, Richard Rudick, Peter Calabresi, Christian Confavreux, Steven Galetta, Gavin Giovannoni, Eva Havrdova, Michael Hutchinson, Ludwig Kappos, Fred Lublin, David Miller, Paul W. O'Connor, J. Phillips, Chris Polman, Ernst-Wilhelm Radue, William Stuart, Andrzej Wajgt, Bianca Weinstock-Guttman, Daniel Wynn, Amy Pace, Robert Hyde, Richard Kim, Michael Panzara P04.182 The Contribution of Cerebrospinal Fluid Analysis to the Diagnosis of Multiple Sclerosis after the First Demyelinating Attack Valentina Zipoli, Bahia Hakiki, Emilio Portaccio, Francesco Lolli, Gianfranco Siracusa, Marta Giannini, Sandro Sorbi, Leonardo Pantoni, Francesca Pescini, Maria Pia Amato NEUROPROTECTION AND NEURORECOVERY P04.183 Treatment with the Poly-ADP-Ribosylation Inhibitor, Nicotinamide Protects Against Increased Injury Susceptibility of CA1 Hippocampal Neurons in Aged Animals Roi Wallis, Kimberly Panizzon P04.184 Role of Tooth Loss in Mechanisms of Dysphagia: A Quantitative Study Using Tongue Pressure Measurements in Stroke Patients Nobuko Hirota, Kuni Konaka, Kazuhiro Hori, Takahiro Ono, Saburo Sakoda, Hiroaki Naritomi P04.185 Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Ischemic Stroke Valeria Battistella, Lea B. Da Fonseca, Bianca Gutfien, Regina C. Goldenberg, Juliana Dias, Eduardo Wajnberg, Daniel Mercante, Gabriel R. De Freitas, Rosália MendezOtero, Charles Andre P04.186 GCSF-Mobilized Hematopoietic Stem Cells in CNS Ischemic Lesion MariaClaudia Vigliani, Alice Bartolini, Lorenzo Magrassi, Alessandro Vercelli, Alberto Cat-Berro, Federico Fusaro, Ferdinando Rossi P04.187 A Case of Neuropsychological and SPECT Findings after Bilateral Fornix Infarction Jungmoo Nam, Suntae Hwang, Curie Chung, Jin Chul Paeng,Yu Kyeong Kim, Byung-kun Kim, Ja-Seong Koo, Ohyun Kwon, Park Jongmoo, Jungju Lee P04.188 Quantitative-Genetic Analysis of Vertebral Artery Hypoplasia in Humans Sandra Morovic, Tatjana Skaric-Juric, Miljenka J. Jurasic, Marijana Lisak, Vida Demarin P04.189 Neuroprotective Effects of Carnosine and Its Analogues Against Focal Cerebral Ischemia in Mice Jiangyong Min, Marie-Claude Senut, Eric Greenberg, Ram Bandagi, Daniel Zemke, Mounzer Kassab, Muhammad U. Farooq, Arshad Majid P04.190 Taxol Reduces Infarct Size in Rat Stroke Model William J. Burke MUSCLE DISEASE: CLINICAL EVALUATION AND QUALITY OF LIFE P04.191 Fidelity of Gamma-Glutamyl Transferase in Differentiating Skeletal Muscle from Liver Damage Xiomara Rosales, Mary Chu, Christopher Shilling, Cheryl Wall, Gregory Pastores, Jerry Mendell P04.192 Clinical Significance of Measurement of Aldolase in Myopathies Kenkichi Nozaki, Alan Pestronk P04.193 Diffusion Weighted MR Imaging of Denervated Skeletal Muscle: An Experimental and Clinical Study Andoni Echaniz-Laguna, Nathalie Holl, Guillaume Bierry, Michel Mohr, JeanPhilippe Loeffler, Jean-Louis Dietemann, Stephane Kremer P04.194 Quantification and Standardization of Ultrasound Imaging of Skeletal Muscle Using Backscatter Analysis Craig M. Zaidman, Mark R. Holland, Christian C. Anderson, Alan Pestronk

56

WEDNESDAY, APRIL 16 / 7:00 A.M.­10:00 A.M. MCCORMICK PLACE WEST CONVENTION CENTER / EXHIBITION HALL

P04.195 Health Status in NonDystrophic Myotonia: Close Relation with Pain and Fatigue Jeroen Trip, Jolanda De Vries, Gea Drost, Baziel van Engelen, Carin Faber P04.196 The Use of a Brief Neuropsychological Testing Battery in a Treatment Trial for Myotonic Dystrophy Type 1 (DM1) Patients Alexis M. Smirnow, James E. Hilbert, Chad Heatwole, Richard T. Moxley III, Peter Como P04.197 Quality of Life in Patients with Inclusion Body Myositis Reza Seyedsadjadi, Michael Rose, Muscle Study Group P04.198 The Relative Contributions of Disease Severity, Mood and Illness Perceptions on the Quality of Life of Those with Muscle Disease Reza Seyedsadjadi, Michael Rose, John Weinman, Shree Pandya, Carlayne Jackson, John Kissel, Muscle Study Group P04.199 Palliative Care Services in Families of Patients with Duchenne Muscular Dystrophy Shree Pandya, John Meaney, Jennifer Andrews, Melinda Davis, Palliative Care Group MDSTARNet

POSTER SESSION IV

Abstracts Online Program

The AAN Abstracts Online Program puts 2,000 abstracts at your fingertips! Customize your 2008 Annual Meeting schedule quickly and conveniently with the program's searchable database: · Download onto your PDA · View, build, and print a personalized itinerary · Search by keyword, presentation time, or author name · Export information to your Word files

®

The Annual Meeting in Chicago Features More Than 2,000 Science Presentations

· Make printable notations for reference · Search scientific presentation and a list of educational programs Visit www.abstracts2view.com/aan2008chicago to search the Abstracts Online Program or download a PDA version--and don't forget to pick up your FREE CD version at the AAN Store located on the First Level of the McCormick Place West.

Supported by Ortho-McNeil Neurologics, Inc. 57

Information

untitled

6 pages

Find more like this

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate

303881


You might also be interested in

BETA
Sleep8.qxd
doi:10.1016/j.brainresrev.2004.09.002
Neurogenetics and Pharmacology of Learning, Motivation, and Cognition
Onofrj.fm
Apathy: A Common Psychiatric Syndrome in the Elderly